Since the efficacy of mycophenolate mofetil (MMF) to treat immunoglobulin A (IgA) nephropathy is controversial, we extended our original study by following 40 Chinese patients with established IgA nephropathy for 6 years. All patients were maintained on their angiotensin blockade medication and half were randomized to receive MMF for 6 months. After 6 years, 11 patients required dialysis (2 from the MMF and 9 from the control group). Significantly, only 3 treated (as compared to 10 control) patients reached the composite end point of serum creatinine doubling or end-stage renal disease. Linear regression showed the annualized decline in the estimated glomerular filtration rate was significantly less in the MMF-treated group. Urinary protein...
Background and objectives Current therapy for IgA nephropathy mainly includes renin-angiotensin s...
PubMedID: 18766457Background: Mycophenolate mofetil (MMF) has shown to be a reliable choice in the t...
Immunoglobulin A (IgA) nephropathy (IgAN) is the most common glomerulonephritis worldwide, character...
Since the efficacy of mycophenolate mofetil (MMF) to treat immunoglobulin A (IgA) nephropathy is con...
Since the efficacy of mycophenolate mofetil (MMF) to treat immunoglobulin A (IgA) nephropathy is con...
Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomi...
Background. Mycophenolate mofetil (MMF) is increasingly used to treat primary glomerulopathies. Its ...
Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy.BackgroundMycophenolate m...
IgA nephropathy (IgAN) is now widely recognized as the most common primary glomerulonephritis worldw...
IgA nephropathy (IgAN) is the most common primary glomerulonephritis in developed countries and a le...
Background Endocapillary hypercellularity independently predicts renal outcome in immunoglobulin A n...
Synthesis of aberrant IgA molecules as the key pathogenetic mechanism of immunoglobulin A nephropath...
Background It remains unclear whether immunosuppressive agents are effective in patients with immuno...
RATIONALE & OBJECTIVE: Individuals with IgA vasculitis nephritis (IGAVN) may develop rapidly progres...
Background and objectives Current therapy for IgA nephropathy mainly includes renin-angiotensin syst...
Background and objectives Current therapy for IgA nephropathy mainly includes renin-angiotensin s...
PubMedID: 18766457Background: Mycophenolate mofetil (MMF) has shown to be a reliable choice in the t...
Immunoglobulin A (IgA) nephropathy (IgAN) is the most common glomerulonephritis worldwide, character...
Since the efficacy of mycophenolate mofetil (MMF) to treat immunoglobulin A (IgA) nephropathy is con...
Since the efficacy of mycophenolate mofetil (MMF) to treat immunoglobulin A (IgA) nephropathy is con...
Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomi...
Background. Mycophenolate mofetil (MMF) is increasingly used to treat primary glomerulopathies. Its ...
Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy.BackgroundMycophenolate m...
IgA nephropathy (IgAN) is now widely recognized as the most common primary glomerulonephritis worldw...
IgA nephropathy (IgAN) is the most common primary glomerulonephritis in developed countries and a le...
Background Endocapillary hypercellularity independently predicts renal outcome in immunoglobulin A n...
Synthesis of aberrant IgA molecules as the key pathogenetic mechanism of immunoglobulin A nephropath...
Background It remains unclear whether immunosuppressive agents are effective in patients with immuno...
RATIONALE & OBJECTIVE: Individuals with IgA vasculitis nephritis (IGAVN) may develop rapidly progres...
Background and objectives Current therapy for IgA nephropathy mainly includes renin-angiotensin syst...
Background and objectives Current therapy for IgA nephropathy mainly includes renin-angiotensin s...
PubMedID: 18766457Background: Mycophenolate mofetil (MMF) has shown to be a reliable choice in the t...
Immunoglobulin A (IgA) nephropathy (IgAN) is the most common glomerulonephritis worldwide, character...